CVS and Walgreens Near $10 Billion Deal to Settle Opioid Casesnews2022-11-02T21:46:14+00:00November 2nd, 2022|The New York Times|
F.D.A. Confirms Widespread Shortages of Adderallnews2022-10-13T18:04:42+00:00October 13th, 2022|The New York Times|
CVS, Walgreens and Walmart Must Pay $650.5 Million in Ohio Opioids Casenews2022-08-17T21:04:19+00:00August 17th, 2022|The New York Times|
Pharmacies Limit Emergency Contraceptive Purchases as Demand Surgesnews2022-06-27T23:38:55+00:00June 27th, 2022|The New York Times|
Angry Customers, More Work and Longer Hours Strain Pharmacistsnews2022-02-10T10:00:07+00:00February 10th, 2022|The New York Times|
The Chief of CVS Health Wants to Be Part of People’s ‘Everyday Life’news2022-01-21T14:00:07+00:00January 21st, 2022|The New York Times|
Searching for Pfizer’s Paxlovid Pills When Mom Got Covidnews2022-01-19T15:29:38+00:00January 19th, 2022|The New York Times|
CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Findsnews2021-11-23T23:00:10+00:00November 23rd, 2021|The New York Times|
Specialty Pharmacies Cater to the Blind and Those With Impaired Visionnews2021-09-21T16:28:23+00:00September 21st, 2021|The New York Times|
